Related Experiment Video

Updated: Aug 10, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

Role of HER receptors family in development and differentiation

Patrizia Casalini1, Marilena V Iorio, Enrico Galmozzi

  • 1Molecular Targeting Unit, Department of Experimental Oncology, Istituto Nazionale Tumori, Milan, Italy. patrizia.casalini@istitutotumori.mi.it

Journal of Cellular Physiology
|July 16, 2004
PubMed

Insights

The epidermal growth factor receptor (EGFR) family, including HER-2, EGFR, and HER-3, is crucial in development and cancer. These receptors mediate cell proliferation, differentiation, and apoptosis, influencing oncogenesis.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases is vital for cellular processes.
  • Overexpression of HER-2, EGFR, and HER-3 is frequently observed in human carcinomas, particularly breast and squamous cancers.
  • EGFR family members mediate biological activities through complex ligand-receptor and receptor-receptor interactions.

Purpose of the Study:

  • To discuss the critical role of the EGFR family in development and oncogenesis.
  • To highlight the significance of HER-2/Neu as a central receptor and preferred heterodimerization partner.
  • To emphasize the pathways and cellular responses mediated by these receptors and their ligands.

Main Methods:

  • Literature review and synthesis of existing research on EGFR family signaling.
  • Analysis of the involvement of HER-2, EGFR, and HER-3 in various human carcinomas.
  • Discussion of receptor-receptor interactions and downstream signaling pathways.

Main Results:

  • The EGFR family plays a fundamental role in both normal development and the progression of cancer.
  • HER-2/Neu acts as a key component in the EGFR signaling network, facilitating heterodimerization with other family members.
  • These receptors and their ligands regulate essential cellular functions like proliferation, differentiation, and apoptosis.

Conclusions:

  • The EGFR family, particularly HER-2, is implicated in oncogenesis due to its overexpression in cancers.
  • Understanding EGFR signaling pathways is crucial for comprehending development and cancer biology.
  • Targeting EGFR family interactions offers potential therapeutic strategies for cancer treatment.

More Related Videos

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells09:32

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells

Published on: February 27, 2020

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: